Multicenter, open-label, exploratory clinical trial with Rhodiola rosea extract in patients suffering from burnout symptoms
Siegfried Kasper,1 Angelika Dienel2 1Universitätsklinik für Psychiatrie und Psychotherapie, Medizinische Universität Wien, Wien, Austria; 2Dr Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany Purpose: This study is the first clinical trial aiming to expl...
Guardado en:
Autores principales: | Kasper S, Dienel A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4e3544b13e564edbaf451e39ca46872e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Preclinical Evidence and Possible Mechanisms of Rhodiola rosea L. and Its Components for Ischemic Stroke: A Systematic Review and Meta-Analysis
por: Yan Li, et al.
Publicado: (2021) -
A preliminary assessment of a combination of rhodiola and saffron in the management of mild–moderate depression
por: Bangratz M, et al.
Publicado: (2018) -
Lack of salidroside impact on selected cytochromes encoding genes transcription in the liver of ethanol induced rats
por: Kujawski Radosław, et al.
Publicado: (2021) -
Estimation of reproductive toxicity of the complex plant remedy "Tireoton"
por: Y. G. Razuvaeva, et al.
Publicado: (2016) -
Bacteriemia por Kocuria rosea en un paciente con SIDA
por: Corti,Marcelo, et al.
Publicado: (2012)